Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Refinancing of floating rate loans - Totalkredit A/S
-
Refinancing of floating rate loans - Nykredit Realkredit A/S
-
Man Group PLC : Form 8.3 - Redrow plc
-
Curaleaf Responds to Miller Amendment to NDAA / Farm Bill
-
Man Group PLC : Form 8.3 - Barratt Developments plc
-
Man Group PLC : Form 8.3 - Tyman plc
-
MUSEWIRE ranked #35 among the top 70 Music Industry Blogs for 2024
-
Tyfon and Global Technology Acquisition Corp. I Announce Public Filing of Registration Statement on Form F-4 in Connection with Proposed Business Combination
-
Core Nickel Grants Stock Options
-
Vext to Announce Financial Results for Q1 2024 on May 29, 2024
-
Netlist Wins $445 Million in Patent Infringement Trial Against Micron
-
Pasinex Announces Anticipated Late Filing of Q1 2024 Interim Filings
-
YS Biopharma Announces Name Change to LakeShore Biopharma
-
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
-
Gulf & Pacific Equities Corp. reports on First Quarter Results with Revenue of $1,087,886
-
Aramark Named to Fair360's 2024 Top 50 Companies and Top Companies for Black Executives Lists
-
BridgeBio Pharma to Present Additional Analyses from the Phase 3 ATTRibute-CM Study of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) at the 2024 ISA Meeting
-
Ollie’s Bargain Outlet Winning Bidder in Bankruptcy Auction to Acquire Eleven Former 99 Cents Only Stores
-
BULGOLD Announces Filing of First Quarter Financial Results for Three Months Ended March 31, 2024
-
Tapestry's Eric Chavous Selected for Minority Corporate Counsel Association’s 2024 Sources of Success(TM) Program
-
XCMG Machinery Amplifies Presence in Latin America with More Tailor-Made Machines Launched
-
Syntec Optics Holdings, Inc. (Nasdaq: OPTX) Reports Fourth Quarter 2023, Full Year 2023 and First Quarter 2024 Financial Results
-
AGF Investments Announces Revised Final Distribution for AGF Systematic Emerging Markets Equity ETF
-
AGF Investments Announces May 2024 Cash Distributions for AGF Enhanced U.S. Equity Income Fund, AGF Total Return Bond Fund and AGF Systematic Global Infrastructure ETF
-
Announcement of drawings (CK95) - Totalkredit A/S
-
Announcement of drawings (CK95) - Nykredit Realkredit A/S
-
Kvika banki hf.: Kvika completes tap issue in SEK
-
A Positive State of Well-Being
-
Alipay Supports Xi’an to Build “International Consumer Friendly Tourist Destination”
-
Rokid AR Lite: The first AR glasses powered by Snapdragon® 6 Gen 1 mobile platform
-
Notification of executives and related parties’ transactions with Nilfisk shares
-
Titans of Tech: GP Bullhound releases its annual report on the European tech ecosystem
-
Laguna Treatment Center Unveils New Name and Expanded Mission with Ribbon-Cutting Ceremony
-
HI-Bio Presents Positive Interim Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at 61st European Renal Association (ERA) Congress
-
First Majestic Announces Voting Results from Annual General Meeting
-
Matt Epstein Joins Travelzoo's Global Executive Team
-
Dispel Promotes Anton Aberg to Chief Product Officer
-
Unlocking the Next Level: Esteemed fashion leaders assemble in Copenhagen to catalyse and accelerate sustainability progress
-
Christopher Hix joins Brady Corporation Board of Directors
-
AbelZeta Announces Publication of Abstract for ASCO 2024 Annual Meeting
-
THE CATO CORPORATION ANNOUNCES REGULAR QUARTERLY DIVIDEND
-
Alma Unveils Alma Harmony™ and Alma IQ™ in U.S. Market, Advancing Personalization in Aesthetic Treatments
-
Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and Immunotherapeutic Mechanism of Action
-
PathKeeper Surgical Selected to Exhibit at Vizient Innovative Technology Exchange
-
GOTRAX Introduces New Fat Tire Electric Bike, the Alpine
-
BioLineRx Announces Abstract on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating Motixafortide in First-Line Pancreatic Cancer (PDAC) at American Society of Clinical Oncology (ASCO)
-
Air Premia, Celebrates the First Anniversary of Its New York Route with Exceptional Performance
-
Foundation Medicine Announces Details of Over 20 Presentations at the 2024 ASCO® Annual Meeting
-
61st ERA Congress: Semaglutide significantly reduces risk of major kidney disease events, cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease, groundbreak
-
Verastem Oncology Announces the Initiation of a Rolling Submission of NDA to FDA Seeking Accelerated Approval of Avutometinib and Defactinib Combination for the Treatment of Adult Patients with Recurr


